Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

The biomarkers show promise but further large-scale validation study is needed to look into the relationships and mechanistic properties of these potential new biomarkers." Colorectal cancer is ...

The biomarkers show promise but further large-scale validation study is needed to look into the relationships and mechanistic properties of these potential new biomarkers.” Colorectal cancer is ...

In a paper published in Frontiers in Oncology, researchers analyzed one of the largest UK Biobank dataset of protein profiles from healthy individuals and colorectal cancer patients and ...

Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.

“This study results offer valuable insight for identifying potential biomarkers in future proteomic studies and it is hoped this knowledge will eventually help improve treatments for patients with ...

Colitis-associated colorectal cancer is chronically underdiagnosed ... Therefore, using the CNA biomarker in the general, lower-risk surveillance population might require further refinement ...

Robert will provide a high-level overview of biomodal’s bioRXiv preprint, 5 methylcytosine (5mC) and 5 hydroxymethylcytosine (5hmC) are synergistic biomarkers for early detection of colorectal cancer.

Leveraging AI and proprietary insights into colorectal cancer biology, PANProfiler Colon is the second clinical product originating from Panakeia’s PANProfiler multi-omic biomarker profiling ...